Analgesia or Addiction: Implications for Morphine Use After Spinal Cord Injury by Woller, Sarah Ann
  
 
 
 
ANALGESIA OR ADDICTION:  IMPLICATIONS FOR MORPHINE USE AFTER 
SPINAL CORD INJURY 
 
 
A Thesis 
by 
SARAH ANN WOLLER  
 
 
Submitted to the Office of Graduate Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of  
MASTER OF SCIENCE 
 
 
May 2010 
 
 
Major Subject: Psychology 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analgesia or Addiction: Implications for Morphine Use After Spinal Cord Injury 
Copyright 2010 Sarah Ann Woller  
  
 
 
 
ANALGESIA OR ADDICTION:  IMPLICATIONS FOR MORPHINE USE AFTER 
SPINAL CORD INJURY 
 
A Thesis 
by 
SARAH ANN WOLLER  
 
Submitted to the Office of Graduate Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of  
MASTER OF SCIENCE 
 
Approved by: 
Chair of Committee,  Michelle Hook 
Committee Members, James Grau 
 Rajesh Miranda 
Head of Department, Les Morey 
 
May 2010 
 
Major Subject: Psychology 
 iii 
ABSTRACT 
 
Analgesia or Addiction:  Implications for Morphine Use After Spinal Cord Injury. (May 
2010) 
Sarah Ann Woller, B.S., University of Iowa 
Chair of Advisory Committee: Dr. Michelle A. Hook 
  
Up to 65% of individuals with a spinal cord injury (SCI) experience neuropathic 
pain, and cite this as one of the most significant consequences of injury.  Opiate 
analgesics are one of the most effective, but also most concerning, treatments for 
neuropathic pain.  In fact, the use of morphine after SCI can potentiate the development 
of paradoxical pain symptoms, and continuous administration can lead to dependence, 
tolerance, and addiction.  Empirical evidence suggests that the addictive potential of 
morphine decreases when used to treat neuropathic pain, but this has not been studied in 
an SCI model.  These studies, therefore, aimed to investigate the addictive potential of 
morphine in a rodent model of spinal contusion injury. 
These experiments used a conditioned place preference (CPP) paradigm to 
examine whether subjects with SCI would develop a preference in the acute phase of 
injury, and whether a place preference would be expressed after the development of 
neuropathic pain symptoms in the chronic phase of injury.  Results suggest that the time 
of treatment did affect the development of a preference for the morphine-paired context; 
subjects displayed a CPP in the acute, but not the chronic phase of SCI.  In addition, the 
 iv 
findings indicate that spinal neurons are sufficient, but not necessary, for producing a 
morphine-induced place preference.   
Overall, the results suggest that morphine could be used for the clinical treatment 
of neuropathic pain without concerns of addiction.  Although SCI alone did not reduce 
the “addictive” potential of morphine in the acute phase of injury, the lack of preference 
in the chronic phase suggests that addiction may be reduced by molecular changes that 
accompany the development of neuropathic pain.  Moreover, we hypothesize that the 
analgesic effects of morphine acting on spinal and peripheral mu-opioid receptors 
(MOR’s) underlies the development of CPP in the acute phase of injury.  This 
hypothesis is supported by the CPP established with intrathecal morphine administration. 
Nonetheless, the current studies cannot discount the role of supraspinally-mediated 
reward in the development of place preference after injury.  Further work is needed to 
distinguish between the addictive and analgesic properties of morphine.  
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 1 
INTRODUCTION 
Neuropathic pain is one of the most significant consequences of spinal cord 
injury (SCI), and is one of the primary symptoms patients would like to have effectively 
treated (Anderson 2004; Backonja & Stacey 2004).  Approximately 65% of individuals 
with SCI experience pain, and the majority describe the pain as severe or excruciating 
(Perry et al. 2008; Budh & Lundeberg 2005; Siddall et al. 2003). Unfortunately, typical 
pain relievers are often ineffective in treating this pain after SCI, and the pain tends to 
get worse with time rather than better (Katz et al. 2008; Budh & Lundeberg 2005; Zaho 
et al. 2004).  Moreover, it has been demonstrated in both animal models and human 
studies that administration of analgesics, such as morphine, can potentiate the 
development of neuropathic pain, allodynia, and hyperalgesia (Liang et al. 2008; Chang 
et al. 2007; Hook et al. 2007; Parisod et al. 2003; Yu et al. 1997a&b). Considering the 
number of people that neuropathic pain affects, it is important that it can be effectively 
treated.  1 
 Opiates are commonly used for the treatment of neuropathic pain after SCI 
(Sindrup & Jensen 1999; Liang et al. 2008; Przewlocki et al. 2005; Clark 2002; Warms 
et al. 2002; Widerstrom-Noga & Turk 2003; O’Conner & Dworkin 2009), and are 
considered to be among the most effective analgesics (Warms et al. 2002).  From a 
clinical perspective, however, the prescription of opiates is concerning because 
continuous administration can lead to dependence, tolerance, and addiction (Trescot et 
al. 2008; Ballantyne & Mao 2003; O’Conner & Dworkin 2009).  It is estimated that 18-
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45% of individuals using opioids for the management of chronic pain, or pain that lasts 
beyond the usual course of disease or healing, abuse the drug (Contet et al. 2008; Trescot 
et al. 2008; Compton & Volkow 2005; Heinemann et al. 1992; Morasco & Dobscha 
2008).  Contradictions between reports on the incidence of addiction, resulting in the 
large reported range, stem from different definitions of abuse, methods of reporting, 
populations being surveyed, and a general lack of empirical research examining the 
efficacy of long-term opioid use and addictive potential (Morasco & Dobscha 2008; 
Dersh et al. 2008; Bell & Salmon 2009; Radnitz & Tirch 1995; Hojsted & Sjogren 
2007).  Clearly, the use of opioids for the management of pain must be further 
investigated. 
While addiction is seen in individuals using opiates for the treatment of chronic 
pain, studies of human and animal subjects suggest that there is a low risk of abuse in 
neuropathic pain conditions (Martin et al. 2007; Ballantyne & Mao 2003; Clark 2002; 
Vetulani 2001).  Thus, the addictive potential for opiates following chronic pain, or pain 
that lasts beyond the usual course of a disease, may differ from the addictive potential in 
conditions of neuropathic pain, or pain resulting from a nerve injury.  Supporting the 
claim that neuropathic pain results in decreased addictive potential for opiates, Bardo et 
al. (1986) showed that morphine is capable of inducing a place preference after a single 
pairing in intact rats, but morphine will not produce a conditioned place preference 
(CPP) in rats experiencing neuropathic pain resulting from nerve ligation (Ozaki et al. 
2002).  Moreover, Lyness et al. (1998) found that arthritic rats self-administered 
significantly less morphine than their pain-free counterparts.  These studies suggest that 
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morphine will not be addictive after SCI. However, a decreased addictive potential after 
SCI cannot be assumed.  Studies have clearly demonstrated that opiates have differential 
effects that depend on the model, the pain assessment tool, and the route of analgesic 
administration (Yu et al. 1997a&b).  Furthermore, if prior behavior is predictive of 
addictive potential, one might expect an increased incidence of addiction after SCI.  
Heinemann et al. (1988) found that up to 62% of SCI patients had misused drugs or 
alcohol at the time of their injury.  Finally, the prevalence of opiate abuse in patients 
with chronic back pain underscores the need to further examine addiction with the 
treatment of neuropathic pain after SCI. 
 To address this issue, the current studies investigate the addictive potential of 
morphine in a rodent contusion model of SCI. The contusion model closely resembles 
the clinical condition of SCI (Hulsebosch 2002), producing symptoms of chronic pain in 
approximately 80% of subjects (Mills et al. 2001).  Rats show signs of thermal, 
mechanical, and girdle allodynia around two weeks following the contusion injury 
(Hulsebosch et al. 2000).  Using this model we examined whether subjects with SCI 
would develop a CPP in the acute phase of injury (Experiment 1), and whether this 
would differ with the development of neuropathic pain symptoms in the chronic phase of 
injury (Experiment 2).  Interestingly, we found that the time of treatment did affect the 
development of a preference for the morphine-paired context; subjects displayed a CPP 
in the acute but not the chronic phase of SCI.  Experiments 3 and 4 examined the 
necessity and sufficiency of spinal neurons in the development of a CPP.  The results 
indicate that spinal neurons are capable of producing a morphine-induced place 
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preference, but this preference was not blocked by the intrathecal administration of 
naltrexone. 
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GENERAL METHODS 
Subjects 
 Male, Sprague-Dawley rats obtained from Harlan (Houston, TX) were used as 
subjects.  Animals were 90-110 days old (350-400 g), and were individually housed in 
Plexiglas bins [45.7 (length) x 23.5 (width) x 20.3 (height) cm] with food and water 
available ad libitum.  Subject’s bladders were expressed manually in the morning (8-
9:30 a.m.) and evening (6-7:30 p.m.) until they regained bladder control, which was 
defined as three consecutive days with an empty bladder at the time of expression.  
Animals were maintained on a 12-hour light-dark cycle and all behavioral testing 
occurred during the light portion of the cycle. 
 All of the experiments were reviewed and approved by the institutional care 
committee at Texas A&M and all NIH guidelines for the care and use of animal subjects 
were followed. 
Surgery 
 For the contusion injury, subjects were anesthetized with inhaled isoflurane (5% 
to induce anesthesia and 2-3% for maintenance), and an area approximately 4.5 cm 
above and below the injury site was shaved and disinfected with iodine.  A 7.0 cm 
incision was made over the spinal cord, and two incisions extending 3 cm rostral and 
caudal to T12-T13 were made on either side of the vertebral column.  The dorsal spinous 
processes at T12-T13 were removed (laminectomy), exposing spinal tissue.  The 
vertebral column was then fixed within the MASCIS device (Constantini and Young 
1994; Gruner 1992) and a moderate contusion injury was produced by allowing the10 g 
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impactor (outfitted with a 2.5 mm tip) to drop 12.5 mm.  The wound was closed with 
Michel clips.  Sham subjects received a laminectomy only (no weight drop), and intact 
subjects received anesthesia only. 
In Experiments 3 and 4, an intrathecal catheter was implanted immediately after 
the contusion injury.  For this procedure, a 15-cm polyethylene (PE-10) cannula, fitted 
with a .23 mm (diameter) stainless steel wire (SWGX-090, Small Parts), was inserted 
into the subarachnoid space under the vertebrae and 2 cm caudal to the injury.  The 
tubing was secured to the vertebrae rostral to the injury site with an adhesive 
(Cyanoacrylate) to prevent movement of the cannula.  The wire was removed from the 
tubing, and the wound was closed with Michel Clips.  
For the first 24 hours after surgery, rats were housed in a recovery room 
maintained at 26.6°C.  All subjects were treated with 100,000 units/kg Pfizerpen 
(penicillin G potassium) immediately after surgery and again 2 days later.  To help 
maintain hydration, subjects were also given 3.0 ml of saline (i.p. injection) following 
surgery. Michel clips were removed 14 days following surgery.   
Assessment of Motor and Sensory Recovery 
Locomotor Recovery.  Locomotor behavior was assessed using the Basso, 
Beattie, and Bresnahan (BBB) scale (Basso et al. 1995) in an open enclosure (99 cm 
diameter, 23 cm deep) on the day following injury.  Subjects were acclimated to the 
apparatus for 5-min per day for 3 days prior to surgery.  Twenty-four hours after surgery 
each subject was placed in the open field and observed for 4-min to assess locomotor 
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behavior.  All observers had high intra- and inter-observer reliability (all r’s>.89) and 
were blind to the subject’s experimental treatment. 
 Locomotor scores were transformed to help assure that the data were amendable 
to parametric analyses (Ferguson et al. 2004a). This transformation pools BBB scores 2-
4, removing a discontinuity in the scale. The transformation also pools scores from a 
region of the scale (14-21) that is very seldom used for a moderate contusion injury. By 
pooling these scores, we obtain an ordered scale that is relatively continuous with units 
that have approximately equivalent interval spacing. Meeting these criteria allows us to 
apply metric operations (computation of mean performance across legs), improves the 
justification for parametric statistical analyses, and increases statistical power. 
Mechanical Reactivity. Reactivity was assessed using von Frey stimuli formed 
from nylon monofilaments (Semmes-Weinstein Anesthesiometer; Stoelting Co., 
Chicago, IL) and applied to the plantar surface of the hindpaws.  Subjects were placed 
into Plexiglas tubes [7.0 cm (internal diameter) x 20 cm (length)] that had 6 cm (length) 
x 1.7 (width) cm notches removed from the sides, to allow the hindlimbs to hang freely.  
After a 15-min acclimation period, the von Frey stimuli were applied sequentially at 
approximately 2 sec intervals until subjects withdrew the paw and vocalized.  If no 
response was observed, testing was terminated at a force of 300 g.  Each subject was 
tested twice on each foot in a counterbalanced ABBA order.  Test sequences were 
spaced 2 min apart.  Stimulus intensity was reported using the formula provided by 
Semmes-Weinstein: Intensity= log10 (10,000*g force).  
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Girdle Test.  A grid map of the girdle zone for allodynic responding was made on 
the rats using an indelible marker (44 squares).  A single von Frey filament with bending 
force of 204.14 mN (26 g force) was applied to each point on the grid, and vocalization 
responses were recorded on a grip map of that animal.  For each subject, the total 
number of vocalizations were recorded (Nv) and normalized by the following formula:  
percent vocalizations=(Nv x 100)/total number applications (44). 
Thermal Reactivity. Reactivity to a noxious thermal stimulus was assessed by 
applying radiant heat to the tail.  A 375-W movie light was focused onto the subject’s 
tail using a condenser lens positioned 8 cm below the light source.  The subject’s tail 
was positioned in a 0.5 cm deep groove cut into an aluminum block 4.7 cm below the 
condenser lens. The last 2.5 cm of the tail was taped to a wire hook and attached to an 
elastic band located 11 cm behind the aluminum block, exposing approximately 2 cm of 
the tail to the light source.  The flexibility of the elastic band allowed for a tail flick 
response while maintaining the rat’s tail under the heat source.  The latency to vocalize 
was then assessed.  After both movement and vocalization responses were detected, the 
heat was terminated.  If a subject failed to respond, the test trial was automatically 
terminated after 8 s of heat exposure to avoid tissue damage.  Subjects were placed in the 
apparatus for 15 min prior to testing and were assessed 3 times at 2 min intervals.  The 
last two tests were averaged to derive a measure of reactivity. 
Place Preference Procedure 
 Apparatus. Acclimation to the training/testing environments took place in grey 
plywood boxes [41cm (length) x 41cm (height) x 38 cm (width)] with smooth floors.  
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Morphine place preference conditioning occurred in one of two distinct environments.  
One box [41cm (length) x 41cm (height) x 38cm (width)] was black with a smooth 
Plexiglas floor scented with 3% vinegar.  The other was a white box and the floor was 
covered with pine chips.  The boxes were cleaned with a disinfectant (Novalsan) 
between subjects. Testing occurred in a box [91cm (length) x 41cm (height) x 38 cm 
(width)] that was comprised of both of the training contexts separated by a neutral grey 
strip. The conditioning boxes and test box were illuminated in a manner that eliminated 
the natural preference for the black or white portion of the box, and were maintained in 
the same position for the duration of the experiment. 
Acclimation. The subjects were brought into the room and were placed into the 
grey acclimation boxes (described previously) for 45-min.  This was done to familiarize 
rats with the handling, environment, and apparatus (see Figure 1A).  
Baseline Preference.  Animals were observed for 15-min in the testing box (with 
the black context and white context separated by a neutral grey strip) to assess baseline 
preference prior to training (see Figure 1C). 
Training. As in previous designs (e.g. Ferguson et al. 2004b), training occurred in 
morning and afternoon (5-hrs later) sessions, allowing animals to experience both the 
drug and saline-paired context in the same day.  Animals were given an injection of 
morphine or 0.90% saline, and were placed in a training context (black or white) for 45-
min before being returned to their home cage for 5-hrs.  In the afternoon session, 
subjects were injected with the other solution (rats that received saline with the first 
injection receive morphine in the second).  Rats were then placed into the other context 
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for 45-min.  In total, rats were given two training trials each day.  One of these trials 
consisted of conditioning of the drug-paired context, and the other involved an injection 
of the vehicle followed by exposure to the vehicle-paired context (see Figure 1B).  Both 
the order of presentation and which context served as the drug-paired environment were 
counterbalanced across individuals.  Baseline preferences for the black/white context 
were balanced across groups. 
Testing. On the day following the last training session, rats were placed in the 
testing chamber and observed for 15-min to assess time spent in the drug-paired context, 
neutral area, and saline-paired context (see Figure 1C). Testing occurred in the middle of 
the day (12:00-14:00 hrs). 
 
 
Data Analyses 
All data were analyzed using an analysis of variance (ANOVA), with an a priori 
alpha value of .05.  Place preference was analyzed by comparing the ratio of the time 
B A C 
Figure 1:  A.  During Acclimation, animals were placed into a grey box for 45-min.  B.  In 
Training, animals were given an injection of morphine or saline paired with one of two 
contexts:  a black chamber with a smooth floor and scented with vinegar, or a white 
chamber with pine chips covering the floor.  Animals experienced both contexts for 45-min 
on each of two days.  C.  Following two days of training, animals were placed in a large box 
with both contexts separated by a neutral grey strip.  Animals were observed for 15-min to 
assess preference.  This box was also used to assess baseline preference before any training 
occurred. 
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spent in the morphine-paired side of the testing chamber to the time spent in the vehicle-
paired context [morphine paired/(saline paired+1)]. 
 12 
EXPERIMENT 1 
Opioid analgesics are one of the only effective pharmacological treatments 
available for neuropathic pain, but no research has been conducted to examine the 
addictive potential of these drugs after SCI.  The aim of this experiment, therefore, was 
to examine whether a place preference for morphine can be established following a 
moderate contusion injury. 
Procedure 
 Experiment 1 used 48 subjects (n=8) randomly assigned to one of two morphine 
sulfate (Sigma–Aldrich, St. Louis) dose conditions (1.25 or 2.5 mg/kg), and one of three 
surgery conditions (contusion, sham, or intact).  Conditioned place preference training 
and testing occurred over 7-days (see Figure 2). 
 
Results  
 Baseline Measures of Motor and Sensory Reactivity.  As expected, locomotor 
scores assessed on the day following surgery were significantly lower in contused 
subjects compared with sham and intact controls (F(2,42)=405, p<.05).  As seen in Figure 
Figure 2.  The timeline used for conditioning of the animals is depicted.  
Animals were acclimated for two days prior to surgery and one additional day 
following surgery when baseline measures of preference and sensory reactivity 
were also recorded.  Training began after surgery, and testing started 4 days post 
injury.  Following all CPP training and testing, sensory reactivity was 
reassessed. 
 
Day 1 & 2: 
Acclimation 
Day 3: 
Surgery 
Day 4:  
Acclimation 
Baseline 
Measures 
Day 5 & 6: 
Training 
Day 7: 
Testing & 
Sensory 
Reactivity 
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3, contused subjects had converted BBB scores indicative of a moderate contusion 
injury; 3.19 ±0.06 in the 1.25 mg/kg group and 4.25 ±0.50 in the 2.5 mg/kg morphine 
group.  Sham subjects in both groups had BBB scores of 12 ±0.00, indicating that they 
displayed consistent plantar placement of the hindpaws and a coordinated gait. 
Subjects were initially assigned to groups based on Day 1 BBB scores.  
However, there were some differences between groups in baseline assessments of 
sensory reactivity.  There was a significant main effect of Surgery on the von Frey tactile 
reactivity task (F(2,42)=5.71, p<.05; see Figure 4A).  Duncan new multiple-range post hoc 
analyses confirmed that contused subjects were significantly less reactive than sham 
subjects (p<.05).  There was also a significant main effect of assigned Dose on tactile 
reactivity (F(1,42)=14.77, p<.05), and an assigned Dose x Surgery interaction (F(2,42)=4.43, 
p<.05).  Subjects in the 2.5 mg/kg morphine group were initially less reactive than those 
in the 1.25 mg/kg group.  For the supraspinal measure of vocalizations in response to 
Figure 3. Animals in the contusion groups showed converted BBB scores indicative 
of a moderate contusion injury.  Sham controls did not differ from Intact controls. 
*p<.05 
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tactile stimulation, there was a significant main effect of Surgery (F(2,42)=3.39, p<.05; see 
Figure 4B).  Sham subjects vocalized at lower von Frey thresholds than contused and 
intact subjects.  To control for these differences in baseline reactivity, a change from 
baseline score (response after place preference training-response prior to place 
Figure 4.   For both motor and vocal reactivity, contused subjects displayed 
higher reactivity thresholds than sham controls (A and B respectively).  These 
data likely reflect the loss of neural function in the acute phase of injury. For 
motor and sensory reactivity to heat, there was also a significant main effect of 
assigned Dose.  Subjects assigned to the 1.25mg/kg group displayed lower 
reactivity thresholds, with a faster tail flick (C) and vocalization (D) response; 
*p<.05, a indicates sham animals were significantly different from contusion and 
intact subjects. 
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preference training) was calculated for subsequent comparisons of reactivity thresholds 
across groups. 
As found on the tests of tactile reactivity, there was a significant main effect of 
assigned Dose on both motor responses and vocalizations elicited by a radiant heat 
stimulus (motor: F(1,42)=23.16, vocalization: F(1,42)=8.37, p’s<.05; see Figure 4 C & D).  
Subjects assigned to the 2.5mg/kg group had longer latencies to exhibit a tail flick and to 
vocalize in response to stimulation than subjects assigned to the 1.25mg/kg group.  To 
control for these baseline differences, a change from baseline score was again used in 
subsequent analyses.  
 Assessment of Place-Preference.  There was a main effect of Surgery condition 
on place preference (F(2,42)=5.06, p<.05).  As displayed in Figure 5, contused subjects 
showed a significantly stronger preference for the morphine-paired context, for both 
drug doses, compared to intact and sham controls.  There was no effect of drug Dose, or 
a Dose X Surgery interaction, on the place preferences observed. Pearson’s Product 
Moment Correlations were used to examine whether any of the baseline reactivity 
measures correlated with preference.  Results indicate neither tactile withdrawal or 
vocalizations nor tail flick motor response or vocalizations correlated with the CPP (all 
r’s <.27). 
 Assessment of Sensory Reactivity After Place Preference Training. Using the 
corrected (change from baseline) index, there were no significant differences between 
groups on the motor response to von Frey stimulation in the tactile reactivity task 
(F(2,42)<1.0, p>.05).  There was, however, a significant main effect of surgery condition 
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when vocalizations in response to tactile stimulation were examined (F(2,42)=5.10, 
p<.05).  The contused and sham subjects both differed from intact controls (p<.05). 
Intact controls vocalized at lower thresholds after place preference testing (Figure 6).  
There were no significant differences across groups on the tests of thermal reactivity.   
To test whether morphine continued to produce analgesia after repeated 
administrations, all subjects were also given an i.p. injection of morphine (their 
previously assigned dose) and thermal reactivity was re-assessed.  Analyses revealed no 
differences between groups, confirming that both doses of morphine produced 
significant analgesia, relative to vehicle, across groups (motor: F<1.0, vocal: F<1.0, both 
p’s>.05).   
 
 
Figure 5. Assessment of the CPP revealed a significant effect of surgery condition.  
Contused subjects showed an increased preference for the morphine-paired context 
relative to sham and intact controls; *p<.05. 
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Discussion 
Immediately following injury, contused subjects given 1.25 or 2.5 mg/kg i.p. 
morphine showed an increased preference for the morphine-paired context relative to 
sham and intact controls.  This suggests that a contusion injury significantly increases 
the addictive potential of morphine in the acute phase of injury.   
Figure 6. Following training and testing, we found a significant difference in 
vocalizations in response to a tactile stimulus.  Intact controls vocalized at lower 
thresholds than sham and contused subjects *p<.05. 
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EXPERIMENT 2 
Previous work has suggested that neuropathic pain decreases the addictive 
potential of morphine in a nerve injury model (Suzuki et al. 1996; Ozaki et al. 2002; 
Martin et al. 2007). Experiment 1 showed, however, that the addictive potential of 
morphine increased in the acute phase of injury.  We hypothesize that, as symptoms of 
neuropathic pain do not develop until 14 days following a contusion injury, the addictive 
potential of morphine may not decrease until the more chronic phase of SCI.  
Experiment 2 examined whether there is a ‘window of vulnerability’ during which 
subjects are more likely to show a conditioned place preference for morphine following 
SCI. 
Procedure 
This experiment used 60 subjects (n=10) randomly assigned to one of six groups 
in a 2 (day 2 or 14) x 3 (intact, sham, or contusion) experimental design. Subjects were 
conditioned on two separate timelines.  One group of subjects replicated the timeline 
from Experiment 1 using a 2.5 mg/kg dose.  The second group experienced delayed 
training and testing, so that training began 14 days following surgery (Figure 7).  
Results 
Baseline Measures of Motor and Sensory Reactivity.  Locomotor scores for 
contused subjects were, again, indicative of a moderate injury and were significantly 
different from sham controls (F(1,36)=632.33, p<.05).   Also, scores for the Day 1 and 
Day 14 contused groups did not differ.  Mean BBB scores (±SEM) collected on the day 
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following surgery were 2.95 ±0.56 for the Day 2 group and 3.45 ±0.49 for the Day 14 
group.  All subjects in the sham group had converted BBB scores of 12 ±0.00.   
Similarly, there were no significant differences between the groups in baseline 
girdle reactivity or motor responses to tactile stimulation of the hindpaws. There was, 
however, a significant main effect of Surgery on vocal responses to tactile stimulation.  
As found in Experiment 1, sham subjects vocalized at lower thresholds than contused 
subjects (F(2,54)=4.58, p<.05).  Baseline tests of motor responses to the radiant heat 
stimulus also revealed a significant main effect of Surgery (F(2,54)=5.26, p<.05), Day of 
testing (F(1,54)=10.89, p<.05), and a Surgery x Day of testing interaction (F(2,54)=4.64, 
p<.05).  The intact groups had a longer latency to tail flick than the sham and contusion 
groups.  In addition, animals in the 2-day group had significantly longer tail flick 
A. 
B. 
Day 1 & 2: 
Acclimation 
Day 3: 
Surgery 
Day 4:  
Acclimation 
Baseline 
Measures 
Day 5 & 6: 
Training 
Day 7: 
Testing & 
Sensory 
Reactivity 
 
Figure 7.  Conditioning of the animals occurred according to the timelines depicted 
above.  A) This timeline replicates the conditioning schedule of Experiment 1 and 
was used for the Day 2 group.  The Day 14 group was conditioned according to the 
timeline shown in B.  Acclimation began 11 days following surgery, and baseline 
measures were taken on day 13 following surgery.  Training began 14-days post-
injury, and testing on day 16. 
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Day 1: 
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Day 13:  
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latencies than the 14-day group.  Vocalization thresholds did not differ across groups on 
the thermal reactivity test. 
Assessment of Place-Preference.  There was a significant main effect of the Day 
of testing on the amount of time spent in the drug-paired context (F(1,54)=5.10, p<.05).  
As shown in Figure 8, contused subjects in the 2-day group showed an increased 
preference relative to intact controls, replicating the results of Experiment 1.  However, 
none of the subjects in the 14-day group preferred the drug-paired context.   
 
 
Assessment of Sensory Reactivity After Place Preference Training.  As 
predicted, contused subjects at 14 days displayed significantly higher levels of girdle 
reactivity compared to all other groups (F(1,36)=6.69, p<.05), reflecting the development 
Figure 8.  Results of the preference testing revealed a main effect of testing day.  
Contused subjects in the day 2 group replicated the results of Experiment 1 and 
showed a preference for the morphine-paired context (a).  However, none of the 
subjects in the 14-day group preferred the drug-paired context. 
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of neuropathic pain (Figure 9A).  Conversely, however, subjects in the 14-day group 
exhibited a longer latency to tail flick after place preference training (F(1,54)=4.23, p<.05; 
Figure 9B). These seemingly disparate results may reflect differences in the type of pain 
experienced as well as differential modulation of reactivity at spinal and supraspinal loci. 
A tail flick to a radiant heat stimulus can be elicited after a spinal transection.  The 
decreased reactivity to heat, therefore, may reflect an intraspinal modification resulting 
from the loss of motor neurons at the level of injury. By contrast, girdle reactivity may 
be modulated by spinal or supraspinal processes above the injury.  Indeed, there were no 
group differences in latency to vocalize to the radiant heat stimulus.  There were also no 
differences across groups when motor and vocal responses to von Frey stimulation of the 
hindpaws were assessed.   
 
 
Figure 9. A.) On Day 14, contused subjects displayed signs of neuropathic pain, 
with significantly higher levels of girdle reactivity compared with all other groups. 
B.) Animals in the Day 14 groups showed longer tail flick latencies following 
morphine administration than did animals on Day 2. *p’s<.05   
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At the end of place preference training and testing, the analgesic efficacy of 
morphine was reassessed.  We found a significant main effect of Day (F(1,54)=11.01, 
p<.05), and a significant Day x Surgery interaction (F(2,54)=6.90, p<.05).  Further 
analyses revealed animals in the Day 14 group had shorter tail flick latencies than did 
animals in the Day 2 group (F(1,58)=9.01, p<.05), and post hoc analyses revealed this 
effect was driven primarily by Day 14 Intact animals (p<.05).  It seems morphine 
administration, in the Day 14 Intact animals, did not produce robust antinociception, 
however, there were no differences between groups when examining vocalizations in 
response to the thermal stimulus (p>.05). 
Discussion 
 Supporting previous studies, contused subjects that displayed symptoms of at-
level neuropathic pain, did not develop a significant preference for the morphine-paired 
context. This suggests, that in the chronic phase of a moderate contusion injury, the 
addictive potential of morphine is attenuated.   
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EXPERIMENT 3 
 To determine whether non-spinal processes are sufficient to induce a CPP with 
morphine, we examined whether intrathecal naltrexone could block the antinociceptive 
and ‘addictive’ effects of systemic morphine. 
Procedure 
Animals were given a 7µg i.t. naltrexone injection 15-min prior to administration 
of an i.p. injection of 2.5mg/kg morphine.  All place preference training and testing 
occurred as described previously (see Figure 2). To ensure that naltrexone was blocking 
antinociception at the spinal loci, sensory reactivity was assessed following each 
training, and testing, session.  This experiment used 16 rats (n=8). 
Results 
Baseline Measures of Motor and Sensory Reactivity.  There were no differences 
in mean converted BBB scores (±SEM) between groups on the day following surgery.  
Animals in the saline group had scores of 2.06 ±0.47 and animals in the naltrexone 
group had scores of 2.00 ±0.39.  In addition, there were no baseline differences in tests 
of girdle reactivity, motor or vocal responses to mechanical stimuli, or motor or vocal 
responses to a thermal stimulus. 
 To ensure naltrexone was blocking the antinociceptive properties of morphine, 
thermal reactivity was assessed following each training session.  Animals in the two 
conditions (naltrexone or saline) did not have different latencies to exhibit a tail flick or 
vocalize in response to the thermal stimulus following saline treatment on either day.  As 
shown in Figure 10, however, when given morphine animals treated with naltrexone 
 24 
showed significantly lower response latencies than animals given saline (motor: 
F(1,10)=55.76, p<.05; vocalizations: F(1,10)=5.37, p<.05).  This indicates the naltrexone 
was blocking the antinociceptive properties of the systemic morphine.   
 
Assessment of Place-Preference.  When looking at the preference for the morphine-
paired context, there were no differences between the groups (F(1,14)=<1.0, p>.05; Figure 
11). 
Assessment of Sensory Reactivity After Place Preference Training.  When place 
preference training and testing were complete, there were no differences between the 
groups on girdle, mechanical, or thermal reactivity (all p’s>.05).  In addition, the 
Figure 10.  Following training, we tested the efficacy of naltrexone in blocking 
the antinociceptive properties of morphine.  Animals given naltrexone had tail 
flick latencies that were significantly lower than animals given morphine alone. 
*p<.05 
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efficacy of naltrexone was confirmed.  As shown in Figure 12, animals given naltrexone 
prior to morphine showed tail flick latencies comparable to those of animals treated with 
saline alone, and significantly lower than animals given vehicle and morphine (motor: 
F(1,10)=6.14, vocalization: F(1,10)=5.98, p’s<.05).  
Discussion 
 We found that i.t. naltrexone did not block the development of a morphine-
induced place preference when the morphine was delivered systemically.  The tendency 
for attenuated place preference when morphine was co-administered with i.t. naltrexone 
was not significant. This suggests that spinal loci may not be necessary for the induction 
of CPP after SCI.  It seems changes at supraspinal loci may contribute to this preference 
for the morphine-paired context after SCI. 
 
Figure 11.  The assessment of conditioned place preference for the morphine-
paired context revealed no differences between animals receiving i.t saline versus 
i.t. naltrexone. 
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Figure 12.  As found following training, animals given morphine and naltrexone 
following testing had tail flick latencies that were significantly lower than animals 
given morphine alone. *p<.05 
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EXPERIMENT 4 
Experiment 3 suggests that spinal processes are not necessary for the 
development of a CPP.  These findings suggest that a place preference for morphine may 
develop in the absence of analgesia. Nonetheless, the results do not exclude the idea that 
the place preference seen in the acute phase of SCI depends in large part on the 
antinociceptive properties of morphine. Morphine applied directly to the spinal cord, and 
producing antinociception, not reward, may be sufficient for expression of a CPP after 
SCI.  To test this, Experiment 4 examined whether a preference for morphine would 
develop with an intrathecal administration. 
Procedure 
This experiment used 18 subjects (n=6).  Animals received a moderate contusion 
injury, and were conditioned on the same timeline as that presented in Experiment 1 (see 
Figure 2).  Rather than i.p. injections of morphine, however, subjects received an 
intrathecal (i.t.) injection of morphine (10, 30, or 90 µg) or vehicle.  Morphine was 
delivered in 2µl of distilled water and followed by a 20 µl injection of 0.90% saline to 
flush the catheter.  The catheter was placed 2 cm caudal to the injury site to minimize 
supraspinally-mediated effects. 
Results 
Baseline Measures of Motor and Sensory Reactivity.  BBB scores did not differ 
across groups on Day 1 following surgery (F(2,15)=2.05, p>.05).   Subjects had mean 
converted BBB scores (±SEM) of 2.00 ±0.51 in the 10 µg group, 2.58 ±0.46 in the 30 µg 
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group, and 3.25 ±0.63 in the 90 µg morphine group.  All scores were, again, indicative 
of a moderate contusion injury. 
Similarly, there were no group differences on the tests of girdle or tactile 
reactivity and no differences in motor responses to the radiant heat stimulus (all 
p’s>.05).  There was, however, a significant effect of assigned Dose on vocal responses 
(F(2,15)=3.69, p<.05).  Post hoc analysis revealed that subjects assigned to the 10 µg 
group vocalized later than those assigned to the 90 µg group (p<.05). 
Assessment of Place Preference.  As can be seen in Figure 13, there was a 
significant main effect of drug Dose on place preference (F(2,15)=4.99, p<.05).  Rats 
treated with 30 µg of morphine showed a preference for the drug-paired context, while 
those in the 10 µg and 90 µg morphine conditions did not. 
 
 
Figure 13.  When the CPP was assessed, we found a significant preference for the 
morphine-paired context in the 30, but not the 10 or 90 µg groups. *p<.05 
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Assessment of Sensory Reactivity After Place Preference Training.  Following 
place preference training and testing, there were no differences in girdle, mechanical, or 
thermal reactivity when the data were analyzed as a change from baseline.  All doses of 
morphine provided the same level of antinociception (motor: F(2,15)<1.0, vocalization: 
F(2,15)=1.84, p>.05). 
Discussion 
 We found that the delivery of 30 µg morphine directly onto the spinal cord, in the 
acute phase of injury, results in a significant preference for the morphine-paired context. 
The morphine was delivered caudal to the site of injury to minimize supraspinally-
mediated effects, suggesting that the preference is developing for analgesia rather than 
addiction. Taken together, the results of Experiments 3 and 4 suggest that spinal neurons 
are sufficient, but not necessary for acquiring a CPP. 
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CONCLUSIONS 
 These results suggest that a spinal contusion significantly increases the 
preference for a morphine-paired context in the acute, but not the chronic, phase of 
injury.  Two days after injury, subjects showed an increased preference for the 
morphine-paired context relative to intact and sham controls.  By contrast, subjects 
exposed to the morphine-paired context 14 days following injury failed to develop a 
preference. These data are commensurate with previous studies that report a decrease in 
the addictive potential of morphine after the development of neuropathic pain (Suzuki et 
al. 1996; Ozaki et al. 2002; Martin et al. 2007).  
 Pain experienced in the acute phase of injury differs substantially from pain 
experienced in the chronic phase, and these differences may be contributing to the 
development of a conditioned place preference. Whereas a place preference for 
morphine consistently emerged in the acute phase of injury with just two training trials, 
and occurred despite the use of low doses of morphine, a preference was not seen in 
animals experiencing neuropathic pain.  Immediately following injury, animals are 
experiencing nociceptive pain as a result of the surgery, and this type of pain responds 
well to analgesics, such as morphine.  In the chronic phase (14+days), however, most 
animals will have developed neuropathic pain (Mills et al. 2001).  Indeed, in the present 
study, contused subjects showed increased girdle reactivity relative to sham and intact 
controls 14 days following injury.  This is indicative of the development of at-level 
neuropathic pain. Morphine is considered to be one of the most effective treatments for 
neuropathic pain, but in the clinic this type of pain remains difficult to treat and often 
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involves the use of higher doses of opiates (Warms et al. 2002; Ozaki et al. 2003; 
Ballantyne & Mao 2003; Widerstrom-Noga & Turk 2003; Ozaki et al. 2002; Narita et al. 
2004a).   
Interestingly, in the current study subjects with symptoms of neuropathic pain 
did not appear to need a higher dose of morphine for analgesia.  We found that 2.5mg/kg 
of morphine provided antinociception, as measured by the tail flick test, even in the 
chronic phase of injury. These data appear to be in contrast to clinical reports of 
unsatisfactory analgesia with high doses of morphine (Ballantyne & Mao 2003), but they 
concur with other animal studies suggesting that the antinociceptive efficacy of 
morphine is not reduced when the subject is experiencing neuropathic pain (Ozaki et al. 
2003). Similar effects have also been reported for oxycodone, a semisynthetic opioid 
analgesic and µ-opioid receptor (MOR) agonist. Narita et al. (2008) demonstrated that 
while oxycodone did not produce a place preference, the amount needed for 
antinociception appeared to be comparable under conditions of neuropathic pain, and 
anti-inflammatory pain. The differences between the human and animal studies may be 
related to the behavioral assessment tasks used to document analgesia in the empirical 
experiments. In fact, the tail flick test that was used in each of the aforementioned 
studies, may not be an adequate measure of relief from neuropathic pain. In order to 
determine whether 2.5 mg/kg of morphine was providing adequate relief from at-level 
neuropathic pain assessed with a girdle test, a measure of girdle reactivity before and 
after morphine administration is needed. Unfortunately, however, we did not reassess 
girdle reactivity following morphine administration in the chronic phase of injury.  It is 
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possible, therefore, that the lack of place preference seen in the chronic phase of injury 
was due to the reduced analgesic efficacy of low doses of morphine. 
 Alternatively, the lack of place preference observed after the development of 
neuropathic pain symptoms may be due to molecular modifications at a spinal level that 
undermine the rewarding properties of the drug after injury. Narita et al. (2004c) suggest 
that the activation of protein kinase C (PKC), resulting from a sciatic nerve ligation leads 
to the development of neuropathic pain, and is responsible for the attenuation of a 
morphine-induced place preference.  It is thought that PKC activation causes the 
desensitization of µ-opioid receptors (MOR’s), which leads to their dysfunction (Narita 
et al. 2007).  In support of this, Narita et al. (2004c) have shown that administration of a 
PKC inhibitor, after sciatic nerve injury, re-instates the potential for the development of 
a conditioned place preference.  In addition, it has been demonstrated in intact rats that 
intrathecal administration of a PKC activator leads to the development of hyperalgesia 
and an attenuation of a morphine-induced CPP; symptoms that are reversed when a PKC 
inhibitor is administered (Oe et al. 2004).  These data suggest that PKC activation at the 
spinal level may be playing a role in the suppression of morphine-induced CPP after 
neuropathic pain has developed.   
Furthermore, it is suggested that the activation of PKC may actually be causing 
changes in the endogenous opioid system (Niikura et al. 2008a&b), leading to 
attenuation of the rewarding properties of morphine in the chronic phase of injury.  
Specifically, sciatic nerve ligation has been found to increase the phosphorylation of the 
µ-opioid receptor in the spinal cord, thus decreasing the activity of the receptor (Narita 
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et al. 2004b). It has also been demonstrated that PKC, an activator of MAPK/ERK, leads 
to the release of the endogenous MOR ligand, β-endorphin, at the supraspinal level (Jin 
et al. 2003; Ji et al. 2003; Niikura et al. 2008a&b), which may lead to a decrease in 
MOR function in the ventral tegmental area (VTA).  The VTA contains a high density of 
MOR’s, and, along with the nucleus accumbens (N.Acc.), is critical for the reinforcing 
effects of morphine. µ-Opioid receptor desensitization is thought to occur, specifically, 
through an inhibition of the mitogen-activated protein kinase (MAPK) pathway 
(Polakiewicz et al. 1998). Moreover, a decrease in extracellular signal-regulated kinase 
(ERK) activity (Ozaki et al. 2004; Narita et al. 2004c) has been shown to result in the 
suppression of morphine-induced release of dopamine (DA) in the N.Acc after sciatic 
nerve injury (Narita et al. 2004a). So, in addition to the desensitization of MOR’s, a 
decrease in DA release leads to the suppression of the rewarding properties of morphine.  
These data suggest neuropathic pain conditions cause multiple changes at spinal and 
supraspinal sites that affect the rewarding properties of morphine. 
Neuropathic pain, however, has not developed in the acute phase of SCI. The 
CPP expressed in this phase may be largely due to the antinociceptive rather than 
hedonic properties of morphine. This idea is supported by the finding of a CPP with 
intrathecal morphine administration.  Interestingly, however, even though all doses of i.t. 
morphine produced antinociception in Experiment 4, we only saw the development of a 
morphine-induced place preference for the 30 µg dose.  Again, it appears that the 
antinociceptive efficacy of morphine may, in fact, depend on the experimental test used 
to measure pain reactivity.  Whereas 10 µg of i.t. morphine effectively produces 
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antinociception as measured with the spinally-mediated tail flick task (Yu et al. 1997b), 
it is not typically effective in the relief of supraspinally-mediated mechanical allodynia 
in rodents (Lee et al. 1995; Yaksh & Harty 1987; Ossipov et al. 1995).  In our 
experiments, we only used the tail flick test as an indice of analgesia, and this may not 
have been a comprehensive measure of pain relief.  In fact, other studies have shown that 
30 µg of morphine is the smallest dose that is effective in treating pain (Zhao et al. 2004; 
Hook et al. 2009). Furthermore, 90 µg of morphine can have aversive effects not related 
to analgesia (Chang et al. 2007; Yaksh & Harty 1987), which may be contributing to the 
lack of preference in this group.  It has been demonstrated that high doses of i.t. 
morphine actually cause hyperalgesia (Woolf 1981; Yaksh & Harty 1987).  Decreased 
analgesic effects, and the potential production of paradoxical pain, may have 
undermined the development of a CPP for the 10 and 90 µg doses, respectively.  Overall, 
the finding that intrathecal morphine can mediate the development of a conditioned 
place preference after injury supports the hypothesis that this increased preference in the 
acute phase of injury is based on the antinociceptive effects of the drug.  
The development of the preference for the antinociceptive effects of the drug 
may involve both central and peripheral opioid receptors.  In Experiment 3, we did not 
find a significant difference in the development of a CPP when administering intrathecal 
saline or naltrexone prior to a systemic injection of morphine.  Mu-opioid receptors exist 
both centrally and peripherally, and evidence suggests that peripheral MOR’s can be 
important in alleviating persistent pain (Guan et al. 2008).  In the current experiments, 
systemic morphine may still be acting on the peripheral MOR’s to cause analgesia, while 
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central (spinal) MOR’s are blocked by naltrexone, leading to the apparent, but not 
significant, reduction in preference.  Central MOR’s are typically considered the primary 
site of action for systemic morphine, leading to antinociception, but the peripheral 
MOR’s may play a greater role when chronic pain is a factor (Guan et al. 2008).  While 
these studies were done in the acute phase of injury, when nociceptive pain is present, 
the changes leading to the chronic phase of injury may be developing, leading to an 
increased role of the peripheral MOR’s.  It could also be that, in the acute phase of injury 
and before neuropathic pain has developed, the supraspinal reward systems are still 
intact and are contributing to the development of the preference.  Further research is 
needed to determine the roles of spinal, peripheral, and supraspinal systems in the 
development of a CPP following injury. 
Overall, these studies suggest that SCI itself does not reduce the addictive 
potential of morphine, but addiction may be reduced by neuropathic pain. Morphine is 
one of the most effective treatments for neuropathic pain, but concerns of dependence 
and addiction surround its use.  The data reported here indicate that morphine could be 
used for the clinical treatment of neuropathic pain without concerns of addiction or 
psychological dependence.  However, further research is needed to distinguish between 
the analgesic and addictive properties of morphine.  In these studies, we used very low 
doses of morphine and an acute administration.  These results may be quite different 
with chronic administration, and with use of higher doses of morphine as analgesic 
tolerance begins to develop.  Overall, studies of place preference with the rodent 
contusion injury provides a tractable translational model to further examine changes in 
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the addictive potential of morphine, and other opiates, as neuropathic pain develops.  
The contusion injury also provides a model system for the investigation of molecular 
changes that could reduce the potential for addiction, and even facilitate withdrawal in 
rehabilitation centers. 
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